International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 3
May-June 2026
Indexing Partners
Development and Validation of a Simple Rp-hplc Method for the Estimation of Palbociclib in Bulk and Pharmaceutical Dosage Form
| Author(s) | Dr. Syeda Kulsum, Dr. Ayesha Naz, Pittala Divya, Amena Samreen, Summaiya Tazbeen, Maheen Tazbeen, Syeda Samreen Farhana |
|---|---|
| Country | India |
| Abstract | A simple, accurate, and precise reverse-phase high-performance liquid chromatographic (RP-HPLC) method was developed and validated for the estimation of Palbociclib in bulk and tablet dosage form. Chromatographic separation was achieved using a Waters HPLC system (Alliance 2695) equipped with a PDA detector and Symmetry ODS C18 column (4.6 mm × 150 mm, 5 µm). The mobile phase consisted of acetonitrile and methanol (60:40 % v/v) at a flow rate of 1.0 mL/min. Detection was carried out at 240 nm with an injection volume of 10 µl. The method was validated as per ICH Q2(R1) guidelines for linearity, accuracy, precision, and robustness. The method showed good linearity in the selected concentration range with acceptable correlation coefficient. The developed method was found to be simple, rapid, sensitive, and reproducible. Hence, the method can be successfully applied for routine analysis of Palbociclib in bulk and pharmaceutical dosage forms |
| Keywords | Palbociclib, RP-HPLC, Validation, ICH Q2(R1), Pharmaceutical Analysis |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 3, May-June 2026 |
| Published On | 2026-05-09 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i03.77702 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals